Insulin-like growth factor-I receptor overexpression mediates cellular radioresistance and local breast cancer recurrence after lumpectomy and radiation.
about
Tyrosine kinase signalling in breast cancer: insulin-like growth factors and their receptors in breast cancer.On how CCN6 suppresses breast cancer growth and invasionTargeting the insulin growth factor receptor 1Inhibition of CCN6 (WISP3) expression promotes neoplastic progression and enhances the effects of insulin-like growth factor-1 on breast epithelial cells.Insulin-like Growth Factor 1 Signaling Axis Meets p53 Genome Protection PathwaysModulation of insulin-like growth factor-1 receptor and its signaling network for the treatment of cancer: current status and future perspectivesTumor specific liposomes improve detection of pancreatic adenocarcinoma in vivo using optoacoustic tomographyWeight gain, metabolic syndrome, and breast cancer recurrence: are dietary recommendations supported by the data?Circulating tumor cell identification by functionalized silver-gold nanorods with multicolor, super-enhanced SERS and photothermal resonances.Membrane localization of insulin receptor substrate-2 (IRS-2) is associated with decreased overall survival in breast cancerNorthwestern profiling of potential translation-regulatory proteins in human breast epithelial cells and malignant breast tissues: evidence for pathological activation of the IGF1R IRES.Risk of breast cancer recurrence associated with carbohydrate intake and tissue expression of IGFI receptorTreatment of murine breast cancer cells with antisense RNA to the type I insulin-like growth factor receptor decreases the level of plasminogen activator transcripts, inhibits cell growth in vitro, and reduces tumorigenesis in vivo.Inhibition of the insulin-like growth factor-1 receptor (IGF1R) tyrosine kinase as a novel cancer therapy approachMultiple signaling pathways of the insulin-like growth factor 1 receptor in protection from apoptosis.ATM-dependent expression of the insulin-like growth factor-I receptor in a pathway regulating radiation response.Apoptosis - associated genes and their role in predicting responses to neoadjuvant breast cancer treatment.MicroRNA-21 promotes glioblastoma tumorigenesis by down-regulating insulin-like growth factor-binding protein-3 (IGFBP3).IGF-1 induces expression of zinc-finger protein 143 in colon cancer cells through phosphatidylinositide 3-kinase and reactive oxygen species.Prognostic and predictive value of Phospho-p44/42 and pAKT in HER2-positive locally advanced breast cancer patients treated with anthracycline-based neoadjuvant chemotherapy.WISP3 (CCN6) is a secreted tumor-suppressor protein that modulates IGF signaling in inflammatory breast cancerEvaluation of 99mTc-Z IGF1R:4551-GGGC affibody molecule, a new probe for imaging of insulin-like growth factor type 1 receptor expressionEarly drug development of inhibitors of the insulin-like growth factor-I receptor pathway: lessons from the first clinical trials.Targeting the Insulin-Like Growth Factor 1 Receptor in Ewing's Sarcoma: Reality and ExpectationsInhibition of IGF-1R prevents ionizing radiation-induced primary endothelial cell senescenceThe potential of hypoxia markers as target for breast molecular imaging--a systematic review and meta-analysis of human marker expression.The Molecular Crosstalk between the MET Receptor Tyrosine Kinase and the DNA Damage Response-Biological and Clinical AspectserbB3 recruitment of insulin receptor substrate 1 modulates insulin-like growth factor receptor signalling in oestrogen receptor-positive breast cancer cell lines.Direct involvement of breast tumor fibroblasts in the modulation of tamoxifen sensitivityRole of IGF-1 receptor in radiation response.IGFBP ratio confers resistance to IGF targeting and correlates with increased invasion and poor outcome in breast tumors.Expression of nuclear insulin receptor substrate 1 in breast cancer.Insulin-like growth factor receptor 1 (IGF1R) expression and survival in surgically resected non-small-cell lung cancer (NSCLC) patients.Semi-quantitative scoring of potentially predictive markers for endocrine treatment of breast cancer: a comparison between whole sections and tissue microarrays.The impact of weight gain during adjuvant chemotherapy on survival in breast cancerClinical significance of immunohistochemical expression of insulin-like growth factor-1 receptor and matrix metalloproteinase-7 in resected non-small cell lung cancer.MVP expression in the prediction of clinical outcome of locally advanced oral squamous cell carcinoma patients treated with radiotherapy.Nutrient restriction and radiation therapy for cancer treatment: when less is morePlasma insulin-like growth factor binding protein-3 proteolysis is increased in primary breast cancer.Primary resistance to cetuximab therapy in EGFR FISH-positive colorectal cancer patients
P2860
Q21195187-99B1BD64-73FE-449E-BDF2-11F821F2499CQ24598488-FF3FF322-40D0-4033-9084-0559BC9745ACQ24633750-F1DEFA69-7F56-45C6-8B8D-3E8D960DFEC5Q25257817-26363646-73D4-476E-AB78-D846CE943040Q26742114-BC0E5584-1D8A-4C3E-B114-D6427CBB5A7BQ26852578-9EAC0B61-4C66-44D3-88D7-D66430DA97F3Q27304350-497B1244-A7DE-4D7F-AAE0-D432BA53023CQ30572730-E1B3DCC4-D507-420C-B550-AE630335AC33Q33586566-817B0706-C1BC-4DFC-BC9B-304F76AD1C75Q33801131-EB7224B0-300F-4C36-93AD-97A65D7CC13FQ33843662-427370A4-A9E5-4DE1-8DF5-2BAE8C663181Q33847983-9184CBDE-46B5-49D6-9170-BCA81E67253DQ33918953-0434A694-3F03-457A-9315-8F6734F03AE6Q33925323-C7472F70-4788-496E-8A6D-8707E0AFA3B5Q33959860-88B04EF4-74EF-4CB4-B8D8-FE1BB36AD864Q34098413-41E2C7C0-A698-4F51-B6CD-921804BC01C0Q34114155-03B018D1-077A-4A18-BB5B-DCDF7F878513Q34139065-6F1867A8-191C-464F-B7CB-650805DDFB1EQ34254212-A04D16B6-9B3D-4DCC-B2B6-9B10546F087DQ34455301-2541FB18-45B7-44F1-9BDA-EDF3303B7C2FQ34770011-0B5A3D6C-19D0-4315-A6AD-F4714FB3E9FAQ34996772-C26FA7C3-F6D7-44F4-823F-B1B7723738C1Q35006620-937EB110-D1E5-4AA7-9893-A0B4525D79B2Q35013284-DA5CAAA7-BA48-4E73-9423-89009D82BC43Q35036570-02F67901-E9D6-4433-BE50-6EBD3B6ED694Q35037251-615867BF-61FA-4562-B39F-07420A1DFF0FQ35078950-C6AFEE21-1C80-47B1-A344-35C452482101Q35683561-16F09509-9FE9-47F6-9156-78FE121B88F9Q35757179-517F2276-F3EF-4ED2-AFF1-8D79D87C87ABQ35762239-513DF05F-587A-4E8F-A864-77E55BD115B6Q35836632-CB126D8E-138F-47C7-8264-0328FF105ECEQ35954427-8E8DEF21-7219-48C5-BF4A-4711016E1956Q35994860-E21E5914-2162-49FE-8C5E-F92634AA3EC3Q36026180-0CCD0538-A811-473B-A4D6-0259620EF882Q36160048-797C920F-AF04-4797-B4A4-BD60CF33C967Q36224160-D528B46D-3B87-435A-8BE0-A88007328FF5Q36384063-2FD82DD1-7059-4085-9250-EEF7605D9A05Q36565675-6B27598C-E6A1-4055-B78E-A3373DD2C2FDQ36623079-C36F72E6-FDE2-46DC-ADF6-D620A097F91AQ36755257-064C5FAE-4119-4DC3-85C5-B9F4F57AB0AA
P2860
Insulin-like growth factor-I receptor overexpression mediates cellular radioresistance and local breast cancer recurrence after lumpectomy and radiation.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Insulin-like growth factor-I r ...... fter lumpectomy and radiation.
@en
Insulin-like growth factor-I r ...... fter lumpectomy and radiation.
@nl
type
label
Insulin-like growth factor-I r ...... fter lumpectomy and radiation.
@en
Insulin-like growth factor-I r ...... fter lumpectomy and radiation.
@nl
prefLabel
Insulin-like growth factor-I r ...... fter lumpectomy and radiation.
@en
Insulin-like growth factor-I r ...... fter lumpectomy and radiation.
@nl
P2093
P1433
P1476
Insulin-like growth factor-I r ...... fter lumpectomy and radiation.
@en
P2093
Burgaud JL
Narayanan L
P304
P407
P577
1997-08-01T00:00:00Z